About Clene, Inc. 
Clene, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 4 Schemes (3.47%)
Foreign Institutions
Held by 7 Foreign Institutions (0.29%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Mar 2026)
Net Profit:
-8 Million
Pharmaceuticals & Biotechnology
USD 55 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.75
145.19%
-3.15






